Parkinson's Disease - New project aims to validate digital biomarkers for better treatment of Parkinson's disease
Can't see this email? View it online
   
  Parkinson's Disease  
  The latest Parkinson's disease news from News Medical  
 Pioneering neural recordings lay the groundwork for personalized Parkinson's treatmentsPioneering neural recordings lay the groundwork for personalized Parkinson's treatments
 
Pioneering neural recordings in patients with Parkinson's disease by UC San Francisco scientists lays the groundwork for personalized brain stimulation to treat Parkinson's and other neurological disorders.
 
   New project aims to validate digital biomarkers for better treatment of Parkinson's diseaseNew project aims to validate digital biomarkers for better treatment of Parkinson's disease
 
Parkinson's disease affects seven to ten million patients in Western societies - with an upward trend. Patients suffer from symptoms such as tremors, gait and speech disorders, and memory loss.
 
   Scientists identify mystery protein that explains the origins of Parkinson's DiseaseScientists identify mystery protein that explains the origins of Parkinson's Disease
 
Researchers have made a “vital step” toward inferring the origins of Parkinson’s disease—a neurological condition that is rapidly growing in the world.
 
 Dopamine-releasing brain cells shed light on Parkinson’s disease
 
Dopamine-releasing brain cells shed light on Parkinson’s diseaseScientists have found that botulinum toxin—commonly known as Botox—can expose the inner workings of the brain, in addition to smoothing out wrinkles.
 
 
 Study reveals molecular profiles of Parkinson's disease
 
Study reveals molecular profiles of Parkinson's diseaseThe second most common neurodegenerative disorder is Parkinson’s disease, but despite this, not much is known about the causes of this condition.
 
 
 Researchers describe a new approach to treating Parkinson's disease
 
Researchers describe a new approach to treating Parkinson's diseaseParkinson's disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life.
 
 
 Study identifies single protein key to regulating sex differences in Parkinson’s disease
 
Study identifies single protein key to regulating sex differences in Parkinson’s diseaseNeuroscientists have found that a single protein is critical to controlling sex disparities in the brain’s susceptibility to age-related neuron loss.